Skip to main content

Table 1 Comparison between alive and dead patients affected by COVID-19

From: Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS

 

Alive (n = 69)

Dead (n = 25)

p

Age (year)

62 ± 13

68 ± 12

0.033

Sex M (%)

53 (77)

17 (68)

0.549

Disease duration (day)

7.7 ± 3.3

7.7 ± 3.1

0.942

Lung disease (%)

17 (25)

11 (44)

0.079

Coronary artery disease (%)

14 (20)

3 (12)

0.545

Cardiovascular comorbidities

 Hypertension (%)

44 (64)

19 (76)

0.362

 Diabetes (%)

11 (16)

5 (20)

0.99

 Smoke (%)

7 (10)

8 (32)

0.021

 Obesity (%)

18 (26)

13 (52)

0.025

Treatment

 Anticoagulants (%)

69 (100)

24 (96)

0.097

 Hydroxycloroquine (%)

51 (74)

19 (76)

0.840

 Antivirals (%)

43 (62)

23 (92)

0.005

 Monoclonal antibodies (%)

8 (12)

10 (40)

0.005

 Corticosteroids (%)

14 (20)

6 (24)

0.98

Type of ventilation

 Nasal oxygen (%)

35 (51)

0 (0)

 < 0.001

 Noninvasive ventilation (%)

22 (32)

0 (0)

 < 0.001

 Intubation (%)

12 (17)

25 (100)

 < 0.032

Biochemistry

 Creatinine (mg/dl)

1.3 ± 1.3

2.8 ± 1.4

 < 0.001

 Cardiac Troponin I (pg/l)

365 ± 644

1245 ± 2049

 < 0.002

 D-dimer (ng/ml)

317 ± 557

919 ± 974

 < 0.001

 C-reactive protein (mg/dl)

10.6 ± 19.9

22.8 ± 27.3

 < 0.023

 Procalcitonin (ng/ml)

0.6 ± 1.5

1.8 ± 2.0

 < 0.005

 APTT (sec)

36.8 ± 6.7

40.6 ± 4.3

0.037

 NT-proBNP (pg/ml)

686 ± 1224

3375 ± 3891

 < 0.001

 Interleukine-6 (ng/ml)

33.6 ± 33.4

246.4 ± 87.4

 < 0.001

 PaO2/FiO2 ratio (mmHg)

270 ± 104

117 ± 56

 < 0.001

  1. Value are represented as mean ± standard deviation or absolute value and (%)
  2. APTT partial thromboplastin time, NT-proBNP N-terminal prohormone of brain natriuretic peptide, PaO2 arterial partial pressure of oxygen, FiO2 fraction of inspired O2